FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Emilie Bright

Research Profile

Disorders

Procedures

Anatomy

Chemicals & Drugs

Physiology

Lymphocyte Activation

Living Beings

Co-author Network

Publications

TOP 3
Elisabetta Capriotti; Eric Vonderheid; Christopher J Thoburn; Emilie C Bright; Allan Hess
Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations.
Allan Hess; Christopher J Thoburn; Yuji Miura; Emilie C Bright
Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen.
Yuji Miura; Christopher J Thoburn; Emilie C Bright; S Arai; Allan Hess
Regulation of OX40 gene expression in graft-versus-host disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Emilie Bright (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Elisabetta Capriotti; Eric Vonderheid; Christopher J Thoburn; Emilie C Bright; Allan Hess
Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations.
The Journal of investigative dermatology 2007;127(12):2882-92.
2005: Allan Hess; Christopher J Thoburn; Yuji Miura; Emilie C Bright
Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen.
Clinical immunology (Orlando, Fla.) 2005;114(3):307-19.
2005: Yuji Miura; Christopher J Thoburn; Emilie C Bright; S Arai; Allan Hess
Regulation of OX40 gene expression in graft-versus-host disease.
Transplantation proceedings 2005;37(1):57-61.
2005: Allan Hess; Christopher J Thoburn; Yuji Miura; Emilie C Bright
Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host disease.
Transplantation proceedings 2005;37(1):53-6.
2004: Yuji Miura; Christopher J Thoburn; Emilie C Bright; Michele L Phelps; Tae Kwang Shin; Elizabeth C Matsui; William Matsui; Sally Arai; Ephraim J Fuchs; Georgia B Vogelsang; Richard J Jones; Allan Hess
Association of Foxp3 regulatory gene expression with graft-versus-host disease.
Blood 2004;104(7):2187-93.
2004: Christopher J Thoburn; Yuji Miura; Emilie C Bright; Allan Hess
Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(9):591-603.
2004: Yuji Miura; Christopher J Thoburn; Emilie C Bright; Allan Hess
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):156-70.
2002: Yuji Miura; Christopher J Thoburn; Emilie C Bright; WEIRAN CHEN; Shinji Nakao; Allan Hess
Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD.
Blood 2002;100(7):2650-8.
2001: Yuji Miura; Christopher J Thoburn; Emilie C Bright; M Sommer; S Lefell; M Ueda; Shinji Nakao; Allan Hess
Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.
Blood 2001;98(3):868-76.
2000: ELSKEN VAN DER WALL; T Horn; Emilie C Bright; J L Passos-Coehlo; S Bond; B Clarke; VL Altomonte; K McIntyre; Georgia B Vogelsang; Stephen J Noga; JANICE DAVIS SPROUL; J Thomassen; KV Ohly; S M Lee; John H Fetting; Deborah K Armstrong; Nancy E Davidson; Allan Hess; M John Kennedy
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
British journal of cancer 2000;83(11):1405-11.
1997: Allan Hess; Emilie C Bright; Christopher J Thoburn; Georgia B Vogelsang; Richard J Jones; M John Kennedy
Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide.
Blood 1997;89(6):2203-9.
1997: Allan Hess; Christopher J Thoburn; Emilie C Bright; LR Horwitz
Specificity of effector mechanisms in syngeneic graft-vs-host disease: recognition of the MHC class II invariant chain peptide (CLIP).
Transplantation proceedings 1997;29(1-2):725-7.
1997: Allan Hess; P Ruvolo; A Fischer; LR Horwitz; Emilie C Bright; Christopher J Thoburn
Characterization of the V alpha/V beta autoreactive T-cell repertoire in syngeneic graft-vs-host disease.
Transplantation proceedings 1997;29(1-2):709-11.
1995: A C Fischer; P P Ruvolo; R Burt; L R Horwitz; Emilie C Bright; J M Hess; W E Beschorner; Allan Hess
Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(8):3713-25.
1995: Allan Hess; A C Fischer; L R Horwitz; Emilie C Bright; J M Hess
Immunological mechanisms governing tolerance to self-major histocompatibility complex antigens after bone marrow transplantation.
Transplantation proceedings 1995;27(1):1370-3.
1995: P Ruvolo; Emilie C Bright; M J Kennedy; L Morris; A Fischer; Georgia B Vogelsang; Richard J Jones; Allan Hess
Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.
Transplantation proceedings 1995;27(1):1363-5.
1994: Allan Hess; A C Fischer; LR Horwitz; Emilie C Bright; M K Laulis
Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(1):400-11.
1991: Allan Hess; Emilie C Bright
The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Transplantation 1991;51(6):1232-40.
1991: Allan Hess; Emilie C Bright
Cyclosporine inhibits T-cell activation at two distinct levels: role of the CD 28 activation pathway.
Transplantation proceedings 1991;23(1 Pt 2):961-6.
1989: Paul M Colombani; Emilie C Bright; M Wells; Allan Hess
Drug-drug interaction between cyclosporine and agents affecting calcium-dependent lymphocyte proliferation.
Transplantation proceedings 1989;21(1 Pt 1):840-1.
1988: Paul M Colombani; Emilie C Bright; Allan Hess
Comparison of binding to peripheral blood lymphocytes between active and inactive derivatives of cyclosporine.
Transplantation proceedings 1988;20(2 Suppl 2):46-50.
1987: A D Donnenberg; Allan Hess; S C Duff; Emilie C Bright; Stephen J Noga; S D Rowley; R Saral; G W Santos
Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxis.
Transplantation proceedings 1987;19(6 Suppl 7):144-52.
1987: Paul M Colombani; Emilie C Bright; O Monastyrskyj; Allan Hess
Subcellular action of cyclosporine: interaction between CsA and calmodulin antagonists.
Transplantation proceedings 1987;19(1 Pt 2):1171-4.